Dec 17,2019

Pear Therapeutics Announces First Patient Dosed in Part II of Pear-006 Feasibility Study to Treat Depressive Symptoms in People with Multiple Sclerosis

Pear Therapeutics today announced the first patient dosed in part II of the first clinical study evaluating Pear-006, a digital therapeutic product candidate for addressing depressive symptoms in Multiple Sclerosis (MS). The randomized controlled trial will enroll approximately 30 patients with Relapsing MS for eight weeks treatment with digital therapy and evaluate dosing, patient use, engagement, and other clinical outcomes.

PRODUCT

#pdt

#cbt

View Analyst & Ambassador Comments
Go to original news
Jul 22,2019

Pear Therapeutics' digital insomnia therapeutic will put FDA's PreCert framework through its paces

Prescription digital therapeutics company Pear Therapeutics announced late last week that it has filed an FDA marketing authorization for Somryst, its digital cognitive behavioral therapy for the treatment of adults with chronic insomnia and depression. While an approval from the agency would mark the third authorized prescription digital therapeutic for Pear — behind reSET for substance use disorder and reSET-O for opioid use disorder — the Somryst application is also the first product to CEO and President Dr. Corey McCann’s knowledge submitted through the FDA’s Precertification Program’s Working Model.

PRODUCT

#mobile app

#cbt

View Analyst & Ambassador Comments
Go to original news
Feb 06,2019

Big Health follows up Sleepio with Daylight, an app for anxiety

Big Health, the London and San Francisco-based digital health app company behind CBT-based sleep app Sleepio, has released its second app, Daylight, which is focused on combating worry and anxiety. Like Sleepio, the app is based on cognitive behavioral therapy. It was developed by a group of creatives the company describes as "leading podcast producers, filmmakers, designers and animators, including veterans of Pixar and NPR’s Radiolab", with scientific support from Boston University, University of California, Los Angeles, University of Oxford and University of Texas, Austin.

PRODUCT

#mobile app

#cbt

View Analyst & Ambassador Comments
Go to original news
Apr 03,2019

Digital tools can help patients, but prescribing the right app is no simple feat

A staggering number of health apps are being released with each passing year, many of which could have a lasting impact on patients entering the health system with stress, anxiety or depression. That sheer volume of options comes at a cost, however, as many therapists and clinicians who are interested in recommending a digital tool or service to their patients simply don’t have the time to comb through the App Store for the perfect tool. At HXD 2019, a team from Kaiser Permanente described their efforts to build and populate a mental health app ecosystem for their clinicians. So far the team’s app prescription ecosystem is comprised of just six mental health apps, three of which focus on mindful meditation and three of which are based on CBT.

#mobile app

#cbt

View Analyst & Ambassador Comments
Go to original news
Apr 04,2019

Pear Therapeutics director outlines challenges of regulated software design

Figuring out the best user experience can be a tricky process for any platform. But its particularly important in digital therapeutics, which some view as a disruptor to traditional pharmaceuticals. Unlike medical drug makers, digital therapeutics companies have UX design to consider during the development of their products, Madhavi Jagdish, director of product designer at Pear Therapeutics, said at Mad*Pow's HXD 2019 in Boston.

PRODUCT

#software

#mobile app

#cbt

View Analyst & Ambassador Comments
Go to original news
May 28,2019

SilverCloud Health Teams Up with Ontario Shores Centre for Mental Health Sciences on a New Initiative

Digital behavioral health company SilverCloud Health is teaming up with Ontario Shores Centre for Mental Health Sciences on a new digital therapeutic initiative, which employs the former's mental health platform. As part of the deal patients with anxiety or depression will be offered SilverCloud’s tool. The program will be offered to individuals receiving care in the outpatient setting, and includes teens, adults and seniors.

COLLABORATION PARTNERSHIP

#institution

#mobile app

#cbt

View Analyst & Ambassador Comments
Go to original news
Aug 06,2019

Digital IBS therapy maker metaMe Health closes $3.8M seed round

Chicago-based metaMe Health, a startup focused on behavioral digital treatments gastrointestinal conditions, has raised $3.8 million in seed funding. LionBird Ventures led the round, which also saw contributions from Hemi Ventures and other unnamed backers. The company’s lead product is Regulora, a treatment tackling the cognitive, behavioral and affective factors that can trigger irritable bowel syndrome (IBS). The startup said that the seed funding will support continued development of Regulora, particularly through the initiation of a large, randomized controlled trial of IBS patients.

FUNDING SEED

#cbt

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 20,2019

Orexo signs partnership agreement with GAIA to develop and commercialize a new digital therapy for the treatment of Opioid Use Disorder

Orexo AB (publ), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces it has entered into an exclusive agreement with GAIA AG (GAIA), a global leader in digital therapeutics that successfully launched its first digital health product in 2001, for a new digital therapy (DTx) for the treatment of Opioid Use Disorder (OUD). Orexo will have the exclusive global commercial rights to the product and intends to launch it in the US in 2022, subject to regulatory approval. The medically assisted treatment of OUD requires a complete treatment plan, including effective medication, such as Orexo’s commercially available Zubsolv®, and counseling and psychosocial support. Orexo believes that the fully-automated DTx (Orexo project no. OXD-01) can become a valuable addition to existing treatment plans.

COLLABORATION PARTNERSHIP

#r&d

#cbt

View Analyst & Ambassador Comments
Go to original news
Sep 27,2019

Ieso Launches Eight Billion Minds to Address Unmet Global Mental Health Needs

Ieso Digital Health, a leader in internet-enabled cognitive behavioural therapy (IECBT), launches Eight Billion Minds, a new digital therapeutics program aiming to address the global and regional shortages of mental health therapists. Eight Billion Minds is building the next generation of mental healthcare based on analysis of real-world clinical data from Ieso’s IECBT platform, ThinkWell™, with a vision to make mental health treatments accessible for all. The company has decoded what works in real-world clinical settings and plans to use new technology to distribute highly personalized therapies on a scale that is just not possible in 1:1 delivery.

PRODUCT

#cbt

View Analyst & Ambassador Comments
Go to original news
Jan 08,2019

Omada Health adds mental health program, gives Lantern Health second life

Omada Health will launch new programs for customers with depression and anxiety, the company announced yesterday. The company has entered into a perpetual licensing agreement with Lantern Health, a digital mental health company that shut down its commercial operations last August, and will integrate Lantern’s software into its existing infrastructure. Additionally, a few members of Lantern’s team will work with Omada to develop and deploy the technology.

COLLABORATION PARTNERSHIP

#product & service

#coaching

#cbt

View Analyst & Ambassador Comments
Go to original news
Subscribe to CBT